Medical device news covering implants, diagnostics, recalls, FDA clearances, and medtech company performance.
Rush University Medical Center surgeons completed the third successful implantation of the ICVP device, which offers artificial vision to patients with total blindness. The wireless system stimulates the visual cortex to enable basic visually guided tasks, marking progress in an ongoing preclinical trial.
Data released after a court order reveals that serious adverse events caused by medical devices in India nearly tripled from 808 to 2,176 between 2020 and 2025. The Indian Pharmacopoeia Commission disclosed these figures only after the Central Information Commission mandated transparency despite objections regarding commercial confidentiality.
A California federal court approved a $45 million settlement for iRhythm Technologies, ending allegations that the company inflated stock prices through misrepresentations about its heart-event monitoring device. The final approval resolves the proposed class action lawsuit.
Philips reports an 8% increase in equipment order intake, signaling long-term health system commitment to its diagnostic platforms. The commentary argues that clinical value prioritization, recurring subscription models, and internal cost cuts are key drivers for investor confidence.
Tombot introduced Jenny, a six-and-a-half-pound robotic dog approved by the FDA, at a Gerontological Society of America conference in Maryland. Designed to mimic a yellow lab, the device helps seniors with dementia manage anxiety through emotional biofeedback.
Siemens Healthineers announced the start of a carve-out process for its in vitro diagnostics business, which will be rebranded as Olyrian Diagnostics. The parent company is simultaneously changing its name to Healthineers, with the full separation targeted for completion by mid-2028.
This commentary analyzes Bausch + Lomb’s third-quarter earnings, arguing that sustained revenue growth and expanding operating leverage signal strong commercial traction. It highlights debt reduction toward strategic targets and premium product adoption as key indicators of long-term investor value and financial health.
Researchers at ETH Zurich have developed a wireless electronic implant that treats type 2 diabetes and obesity by physically breaking down excess blood glucose. In mouse trials, the device normalized blood sugar levels within 90 minutes and reduced body weight by 10% over six weeks without using drugs or insulin.
Three Harvard design engineering students won the 2026 James Dyson Award Global Winner title for Rumble Rims, a wearable device that screens for concussions using infrared eye-tracking. The team received $40,000 to develop the technology, which offers objective sideline data to replace subjective tests.